ALVINO, ESTER
ALVINO, ESTER
Istituto di Farmacologia Traslazionale - (IFT)
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy
2022 Levati, Lauretta; Bassi, Cristian; Mastroeni, Simona; Lupini, Laura; Cappellini, Gian Carlo Antonini; Bonmassar, Laura; Alvino, Ester; Caporali, Simona; Lacal, Pedro Miguel; Narducci, Maria Grazia; Molineris, Ivan; De Galitiis, Federica; Negrini, Massimo; Russo, Giandomenico; D'Atri, Stefania
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
2019 Caporali, Simona; Amaro, Adriana; Levati, Lauretta; Alvino, Ester; Lacal, Pedro Miguel; Mastroeni, Simona; Ruffini, Federica; Bonmassar, Laura; Cappellini, Gian Carlo Antonini; Felli, Nadia; Care, Alessandra; Pfeffer, Ulrich; D'Atri, Stefania
Loss of miR-204 expression is a key event in melanoma
2018 Galasso, Marco; Morrison, Carl; Minotti, Linda; Corra, Fabio; Zerbinati, Carlotta; Agnoletto, Chiara; Baldassari, Federica; Fassan, Matteo; Bartolazzi, Armando; Vecchione, Andrea; Nuovo Gerard, J; Di Leva, Gianpiero; D'Atri, Stefania; Alvino, Ester; Previati, Maurizio; Nickoloff Brian, J; Croce Carlo, M; Volinia, Stefano
Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor
2016 Caporali, S; Alvino, E; Lacal, Pm; Levati, L; Giurato, G; Memoli, D; Caprini, E; Cappellini, Gca; D'Atri, S
Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-B or the PI3K/mTOR signalling pathway
2015 Caporali, Simona; Alvino, Ester; Amaro, Adriana; Miguel Lacal, Pedro; Levati, Lauretta; Grazia Atzori, Maria; Carlo Antonini Cappellini, Gian; Ruffini, Federica; Bonmassar, Enzo; Pfeffer, Ulrich; D'Atri, Stefania
High Expression of the Mismatch Repair Protein MSH6 Is Associated With Poor Patient Survival in Melanoma.
2014 Alvino, Ester; Passarelli, Francesca; Cannavo, Elda; Fortes, Cristina; Mastroeni, Simona; Caporali, Simona; Jiricny, Josef; Cappellini Gian Carlo, Antonini; Scoppola, Alessandro; Marchetti, Paolo; Modesti, Andrea; D'Atri, Stefania
Down-modulation of MMP9 Contributes to the Inhibitory Effects of MicroRNA-146a on Melanoma Cell Invasiveness
2012 Levati, L; Pagani, E; Lacal, P M; Ruffini, F; Bonmassar, E; Alvino, E; D'Atri, S
Down-regulation of MMP9 contributes to the inhibitory effects of microRNA 146 on melanoma cell invasiveness
2012 L Levati; E Pagani; PM Lacal; F Ruffini; E Bonmassar; E Alvino; S D'Atr
Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125.
2012 Caporali, S; Alvino, E; Levati, L; Esposito, Ai; Ciomei, M; Brasca, Mg; Del Bufalo, D; Desideri, M; Bonmassar, E; Pfeffer, U; D'Atri, S
MicroRNA-155 Targets the SKI Gene in Human Melanoma Cell Lines
2011 Levati, Lauretta; Pagani, Elena; Romani, Sveva; Castiglia, Daniele; Piccinni, Eugenia; Covaciu, Claudia; Caporaso, Patrizia; Bondanza, Sergio; Romana Antonetti, Francesca; Bonmassar, Enzo; Martelli, Fabio; Alvino, Ester; Datri, Stefania
MicroRNA-155 targets the SKI gene in human melanoma cell lines
2011 Levati, Lauretta; Pagani, Elena; Romani, Sveva; Castiglia, Daniele; Piccinni, Eugenia; Covaciu, Claudia; Caporaso, Patrizia; Bondanza, Sergio; Antonetti Francesca, R; Bonmassar, Enzo; Martelli, Fabio; Alvino, Ester; D'Atri, Stefania
The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound
2010 Caporali, Simona; Alvino, Ester; cGiuseppe Starace, B; Ciomei, Marina; Gabriella Brasca, Maria; Levati, Lauretta; Garbin, Alberto; Castiglia, Daniele; Covaciu, Claudia; Bonmassar, Bfenzo; D'Atri, Stefania
Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155
2009 Levati, L; Alvino, E; Pagani, E; Arcellid, ; Caporaso, P; Bondanza, S; Di Leva, G; Ferracin, M; Volinia, S; Bonmassar, E; Croce, Cm; D'Atri, S
AKT is activated in an ataxia-telangectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition
2008 Caporali, S; Levati, L; Starace, G; Ragone, G; Bonmassar, E; Alvino, E; D'Atri, S
A syngle cycle of treatment with temozolomide, alone or combined with O6-benzylguanine, induces strong chemoresistance in melanoma cell clones: role of o6-methylguanine-DNA methyltransferase and the mismatch repair system.
2006 Alvino, E; Castiglia, D; Caporali, E; Pepponi, R; Caporaso, P; Lacal, Pm; Marra, G; Fischer, F; Zambruno, G; Bonmassar, E; Jiricny, J; D'Atri, S
The role of PLZF in melanoma progression.
2004 Felicetti, F; Bottero, L; Felli, N; Mattia, G; Labbaye, C; Alvino, E; Peschle, C; Colombo, Mp; Care', A
Biallelic somatic inactivation of the mismatch repair gene MLH1 in a primary skin melanoma
2003 Castiglia, D; Pagani, E; Alvino, E; Vernole, P; Marra, G; Cannavo, E; Jiricny, J; Zambruno, G; D'Atri, S
Chordoma of the skull base: predictors of tumor recurrence
2003 Pallini, R; Maira, G; Pierconti, F; Falchetti, Ml; Alvino, E; Cimino Reale, G; Fernandez, E; D'Ambrosio, E; Larocca, Lm
DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system.
2003 Pagani, E; Pepponi, R; Fuggetta, Mp; Prete, Sp; Turriziani, M; Bonmassar, L; Lacal, Pm; Falcinelli, S; Passarelli, F GUADAGNI F; Alvino, E; D'Atri, S
Long telomeric C-rich 5'-tails in human replicating cells.
2003 Ciminoreale, G; Pascale, E; Alvino, E; Starace, G; D'Ambrosio, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy | 1-gen-2022 | Levati, Lauretta; Bassi, Cristian; Mastroeni, Simona; Lupini, Laura; Cappellini, Gian Carlo Antonini; Bonmassar, Laura; Alvino, Ester; Caporali, Simona; Lacal, Pedro Miguel; Narducci, Maria Grazia; Molineris, Ivan; De Galitiis, Federica; Negrini, Massimo; Russo, Giandomenico; D'Atri, Stefania | |
| miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A | 1-gen-2019 | Caporali, Simona; Amaro, Adriana; Levati, Lauretta; Alvino, Ester; Lacal, Pedro Miguel; Mastroeni, Simona; Ruffini, Federica; Bonmassar, Laura; Cappellini, Gian Carlo Antonini; Felli, Nadia; Care, Alessandra; Pfeffer, Ulrich; D'Atri, Stefania | |
| Loss of miR-204 expression is a key event in melanoma | 1-gen-2018 | Galasso, Marco; Morrison, Carl; Minotti, Linda; Corra, Fabio; Zerbinati, Carlotta; Agnoletto, Chiara; Baldassari, Federica; Fassan, Matteo; Bartolazzi, Armando; Vecchione, Andrea; Nuovo Gerard, J; Di Leva, Gianpiero; D'Atri, Stefania; Alvino, Ester; Previati, Maurizio; Nickoloff Brian, J; Croce Carlo, M; Volinia, Stefano | |
| Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor | 1-gen-2016 | Caporali, S; Alvino, E; Lacal, Pm; Levati, L; Giurato, G; Memoli, D; Caprini, E; Cappellini, Gca; D'Atri, S | |
| Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-B or the PI3K/mTOR signalling pathway | 1-gen-2015 | Caporali, Simona; Alvino, Ester; Amaro, Adriana; Miguel Lacal, Pedro; Levati, Lauretta; Grazia Atzori, Maria; Carlo Antonini Cappellini, Gian; Ruffini, Federica; Bonmassar, Enzo; Pfeffer, Ulrich; D'Atri, Stefania | |
| High Expression of the Mismatch Repair Protein MSH6 Is Associated With Poor Patient Survival in Melanoma. | 1-gen-2014 | Alvino, Ester; Passarelli, Francesca; Cannavo, Elda; Fortes, Cristina; Mastroeni, Simona; Caporali, Simona; Jiricny, Josef; Cappellini Gian Carlo, Antonini; Scoppola, Alessandro; Marchetti, Paolo; Modesti, Andrea; D'Atri, Stefania | |
| Down-modulation of MMP9 Contributes to the Inhibitory Effects of MicroRNA-146a on Melanoma Cell Invasiveness | 1-gen-2012 | Levati, L; Pagani, E; Lacal, P M; Ruffini, F; Bonmassar, E; Alvino, E; D'Atri, S | |
| Down-regulation of MMP9 contributes to the inhibitory effects of microRNA 146 on melanoma cell invasiveness | 1-gen-2012 | L Levati; E Pagani; PM Lacal; F Ruffini; E Bonmassar; E Alvino; S D'Atr | |
| Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125. | 1-gen-2012 | Caporali, S; Alvino, E; Levati, L; Esposito, Ai; Ciomei, M; Brasca, Mg; Del Bufalo, D; Desideri, M; Bonmassar, E; Pfeffer, U; D'Atri, S | |
| MicroRNA-155 Targets the SKI Gene in Human Melanoma Cell Lines | 1-gen-2011 | Levati, Lauretta; Pagani, Elena; Romani, Sveva; Castiglia, Daniele; Piccinni, Eugenia; Covaciu, Claudia; Caporaso, Patrizia; Bondanza, Sergio; Romana Antonetti, Francesca; Bonmassar, Enzo; Martelli, Fabio; Alvino, Ester; Datri, Stefania | |
| MicroRNA-155 targets the SKI gene in human melanoma cell lines | 1-gen-2011 | Levati, Lauretta; Pagani, Elena; Romani, Sveva; Castiglia, Daniele; Piccinni, Eugenia; Covaciu, Claudia; Caporaso, Patrizia; Bondanza, Sergio; Antonetti Francesca, R; Bonmassar, Enzo; Martelli, Fabio; Alvino, Ester; D'Atri, Stefania | |
| The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound | 1-gen-2010 | Caporali, Simona; Alvino, Ester; cGiuseppe Starace, B; Ciomei, Marina; Gabriella Brasca, Maria; Levati, Lauretta; Garbin, Alberto; Castiglia, Daniele; Covaciu, Claudia; Bonmassar, Bfenzo; D'Atri, Stefania | |
| Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155 | 1-gen-2009 | Levati, L; Alvino, E; Pagani, E; Arcellid, ; Caporaso, P; Bondanza, S; Di Leva, G; Ferracin, M; Volinia, S; Bonmassar, E; Croce, Cm; D'Atri, S | |
| AKT is activated in an ataxia-telangectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition | 1-gen-2008 | Caporali, S; Levati, L; Starace, G; Ragone, G; Bonmassar, E; Alvino, E; D'Atri, S | |
| A syngle cycle of treatment with temozolomide, alone or combined with O6-benzylguanine, induces strong chemoresistance in melanoma cell clones: role of o6-methylguanine-DNA methyltransferase and the mismatch repair system. | 1-gen-2006 | Alvino, E; Castiglia, D; Caporali, E; Pepponi, R; Caporaso, P; Lacal, Pm; Marra, G; Fischer, F; Zambruno, G; Bonmassar, E; Jiricny, J; D'Atri, S | |
| The role of PLZF in melanoma progression. | 1-gen-2004 | Felicetti, F; Bottero, L; Felli, N; Mattia, G; Labbaye, C; Alvino, E; Peschle, C; Colombo, Mp; Care', A | |
| Biallelic somatic inactivation of the mismatch repair gene MLH1 in a primary skin melanoma | 1-gen-2003 | Castiglia, D; Pagani, E; Alvino, E; Vernole, P; Marra, G; Cannavo, E; Jiricny, J; Zambruno, G; D'Atri, S | |
| Chordoma of the skull base: predictors of tumor recurrence | 1-gen-2003 | Pallini, R; Maira, G; Pierconti, F; Falchetti, Ml; Alvino, E; Cimino Reale, G; Fernandez, E; D'Ambrosio, E; Larocca, Lm | |
| DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system. | 1-gen-2003 | Pagani, E; Pepponi, R; Fuggetta, Mp; Prete, Sp; Turriziani, M; Bonmassar, L; Lacal, Pm; Falcinelli, S; Passarelli, F GUADAGNI F; Alvino, E; D'Atri, S | |
| Long telomeric C-rich 5'-tails in human replicating cells. | 1-gen-2003 | Ciminoreale, G; Pascale, E; Alvino, E; Starace, G; D'Ambrosio, E |